Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:666-673

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alings, M.
Right arrow Articles by Wilde, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alings, M.
Right arrow Articles by Wilde, A.
Right arrowPubmed/NCBI databases
*OMIM
Medline Plus Health Information
*Cardiac Arrest
Related Collections
Right arrow Clinical genetics
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 1999;99:666-673.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

"Brugada" Syndrome

Clinical Data and Suggested Pathophysiological Mechanism

Marco Alings, MD, PhD; Arthur Wilde, MD, PhD

From the Department of Clinical and Experimental Cardiology, Academic Medical Center, Amsterdam (M.A., A.W.), and the Department of Cardiology, Heart Lung Institute, Utrecht University Hospital (A.W.), Netherlands.

Correspondence to Dr Marco Alings, AMC, Department of Cardiology, PO Box 22700, 1100 DE Amsterdam, Netherlands. E-mail a.m.alings@amc.uva.nl


Key Words: Brugada syndrome • antiarrhythmia agents • arrhythmia • death, sudden • tachyarrhythmias


*    Introduction
 
The occurrence of ventricular fibrillation (VF) in the absence of any structural heart disease is classified as "primary electrical disease" or (in the absence of any relevant findings) "idiopathic VF." This diagnosis implies that the arrhythmogenic substrate is inherent to the excitable and conducting properties of the heart. With the exception of a positive family history, demographic variables are, as a rule, not very helpful in establishing the diagnosis of primary electrical disease.1 The paradigm of primary electrical disease is the long-QT syndrome (LQTS), in which altered ionic channel function secondary to mutations in genes encoding ion channels has been shown to underlie QT-interval prolongation.2 3

In 1992, Brugada and Brugada4 described 8 patients with a history of aborted sudden death and a distinct ECG pattern, consisting of right bundle-branch block (RBBB) with ST-segment elevation in the right precordial leads (V1, V2, and V3, Figure 1Down) and normal QT interval in the absence of any structural heart disease (as determined by routine clinical, biochemical, echocardiographic, and angiographic examinations). In 4 of the reported patients, a family history was suspected.



View larger version (64K):
[in this window]
[in a new window]
 
Figure 1. ECG tracings of 1 patient originally described by Brugada and Brugada.4 Tracings show RBBB with ST-segment elevation in right precordial leads. There is marked left axis deviation, suggesting presence of left anterior hemiblock. In presence of RBBB, QTc is prolonged (482 ms).

Patients with these unique ECG abnormalities have been recognized as a distinct subgroup in male Thai patients presenting with cardiac arrest due to VF.5 . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
B. Surawicz, R. Childers, B. J. Deal, and L. S. Gettes
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part III: Intraventricular Conduction Disturbances A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology
J. Am. Coll. Cardiol., March 17, 2009; 53(11): 976 - 981.
[Full Text] [PDF]


Home page
CirculationHome page
B. Surawicz, R. Childers, B. J. Deal, and L. S. Gettes
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part III: Intraventricular Conduction Disturbances: A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology
Circulation, March 17, 2009; 119(10): e235 - e240.
[Full Text] [PDF]


Home page
PNHome page
E. Marsh, P. O'Callaghan, and P. Smith
The humble electrocardiogram
Practical Neurology, January 1, 2008; 8(1): 46 - 59.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al.
Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function
Circulation, November 13, 2007; 116(20): 2325 - 2345.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. S. Stokoe, R. Balasubramaniam, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang
Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome
J. Physiol., May 15, 2007; 581(1): 255 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. S. Stokoe, G. Thomas, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang
Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/{Delta} murine hearts modelling long QT syndrome 3
J. Physiol., January 1, 2007; 578(1): 69 - 84.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Hallaq, Z. Yang, P. C. Viswanathan, K. Fukuda, W. Shen, D. W. Wang, K. S. Wells, J. Zhou, J. Yi, and K. T. Murray
Quantitation of protein kinase A-mediated trafficking of cardiac sodium channels in living cells
Cardiovasc Res, November 1, 2006; 72(2): 250 - 261.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
EuropaceHome page
B. Sassone, S. Sacca, and M. Donateo
Paradoxical effect of ajmaline in a patient with Brugada syndrome.
Europace, April 1, 2006; 8(4): 251 - 254.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M C S Hall and D M Todd
Modern management of arrhythmias
Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
R. Ogawa, R. Kishi, K. Mihara, H. Takahashi, A. Takagi, N. Matsumoto, K. Masuhara, K. Nakazawa, F. Miyake, S. Kobayashi, et al.
Population Pharmacokinetic and Pharmacodynamic Analysis of a Class IC Antiarrhythmic, Pilsicainide, in Patients With Cardiac Arrhythmias
J. Clin. Pharmacol., January 1, 2006; 46(1): 59 - 68.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. O. Verkerk, R. Wilders, E. Schulze-Bahr, L. Beekman, Z. A. Bhuiyan, J. Bertrand, L. Eckardt, D. Lin, M. Borggrefe, G. Breithardt, et al.
Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome
Cardiovasc Res, December 1, 2005; 68(3): 441 - 453.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Shah, F. G. Akar, and G. F. Tomaselli
Molecular Basis of Arrhythmias
Circulation, October 18, 2005; 112(16): 2517 - 2529.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
E Aksay, T Okan, and S Yanturali
Brugada syndrome, manifested by propafenone induced ST segment elevation
Emerg. Med. J., October 1, 2005; 22(10): 748 - 750.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. Haghjoo, A. Arya, Z. Emkanjoo, and M. A. Sadr-Ameli
Clinical and Electrophysiologic Profile of Brugada Syndrome in Iranian Patients
Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 241 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R. Bezzina, A. A.M. Wilde, and D. M. Roden
The molecular genetics of arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 343 - 346.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. G. Meregalli, A. A.M. Wilde, and H. L. Tan
Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more?
Cardiovasc Res, August 15, 2005; 67(3): 367 - 378.
[Abstract] [Full Text] [PDF]


Home page
Emerg. Med. J.Home page
A T D Mills, S Dasan, and A Wan
Brugada syndrome: syncope in the younger patient and the risk of sudden cardiac death
Emerg. Med. J., August 1, 2005; 22(8): 604 - 606.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. C.M. Beaufort-Krol, M. P. van den Berg, A. A.M. Wilde, J. P. van Tintelen, J. W. Viersma, C. R. Bezzina, and M. Th.E. Bink-Boelkens
Developmental Aspects of Long QT Syndrome Type 3 and Brugada Syndrome on the Basis of a Single SCN5A Mutation in Childhood
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 331 - 337.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
T. T. Beery
The Genetics of Cardiac Arrhythmias
Biol Res Nurs, April 1, 2005; 6(4): 249 - 261.
[Abstract] [PDF]


Home page
CirculationHome page
C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, I. Gussak, H. LeMarec, K. Nademanee, A. R. Perez Riera, et al.
Brugada Syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
Circulation, February 8, 2005; 111(5): 659 - 670.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force members, M. Brignole, P. Alboni, D. G. Benditt, L. Bergfeldt, J.-J. Blanc, P. E. B. Thomsen, J. G. van Dijk, A. Fitzpatrick, S. Hohnloser, et al.
Guidelines on management (diagnosis and treatment) of syncope - Update 2004: The task force on Syncope, European Society of Cardiology
Eur. Heart J., November 2, 2004; 25(22): 2054 - 2072.
[Full Text] [PDF]


Home page
CirculationHome page
B. Martini, H. L. Tan, R. Tukkie, J. Vleugels, I. K.L.M. de Groot, A. A.M. Wilde, and P. Sogaard
Further Confirmation That a Conduction Disturbance Underlies the Electrocardiographic Pattern of the So-Called Brugada Syndrome * Response
Circulation, August 3, 2004; 110(5): e53 - e53.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J. H van Berlo, D. Duboc, and Y. M Pinto
Often seen but rarely recognised: cardiac complications of lamin A/C mutations
Eur. Heart J., May 2, 2004; 25(10): 812 - 814.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M.J Junttila, M.J.P Raatikainen, J Karjalainen, H Kauma, Y.A Kesaniemi, and H.V Huikuri
Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population
Eur. Heart J., May 2, 2004; 25(10): 874 - 878.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. F. D. Wever and E. O. Robles de Medina
Sudden death in patients without structural heart disease
J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1137 - 1144.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Tukkie, P. Sogaard, J. Vleugels, I. K.L.M. de Groot, A. A.M. Wilde, and H. L. Tan
Delay in Right Ventricular Activation Contributes to Brugada Syndrome
Circulation, March 16, 2004; 109(10): 1272 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. M. Sanchez and A. M. Kates
Brugada-type Electrocardiographic Pattern Unmasked by Fever
Mayo Clin. Proc., February 1, 2004; 79(2): 273 - 274.
[PDF]


Home page
EuropaceHome page
P. Maury, P. Couderc, M. Delay, S. Boveda, and J. Brugada
Electrical storm in Brugada syndrome successfully treated using isoprenaline
Europace, January 1, 2004; 6(2): 130 - 133.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
N. Colman, W. Wieling, and A.A.M. Wilde
A patient with recurrent syncope and ST-elevation on the electrocardiogram
Europace, January 1, 2004; 6(4): 296 - 300.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology
Europace, January 1, 2004; 6(6): 467 - 537.
[Full Text] [PDF]


Home page
NEJMHome page
K. Wang, R. W. Asinger, and H. J.L. Marriott
ST-Segment Elevation in Conditions Other Than Acute Myocardial Infarction
N. Engl. J. Med., November 27, 2003; 349(22): 2128 - 2135.
[Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
P. O'Brien and F. Oyebode
Psychotropic medication and the heart
Advan. Psychiatr. Treat., November 1, 2003; 9(6): 414 - 423.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Rolf, H.-J. Bruns, T. Wichter, P. Kirchhof, M. Ribbing, K. Wasmer, M. Paul, G. Breithardt, W. Haverkamp, and L. Eckardt
The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol
Eur. Heart J., June 2, 2003; 24(12): 1104 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, J. A. Towbin, and K. Nademanee
Brugada syndrome: 1992-2002: A historical perspective
J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1665 - 1671.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde
Genetic control of sodium channel function
Cardiovasc Res, March 15, 2003; 57(4): 961 - 973.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. R. Bezzina, M. B. Rook, W.A. Groenewegen, L. J. Herfst, A. C. van der Wal, J. Lam, H. J. Jongsma, A. A.M. Wilde, and M. M.A.M. Mannens
Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System
Circ. Res., February 7, 2003; 92(2): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, W. Shimizu, I. Gussak, and A.R. Perez Riera
Brugada Syndrome: A Decade of Progress
Circ. Res., December 13, 2002; 91(12): 1114 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Noda, W. Shimizu, A. Taguchi, K. Satomi, K. Suyama, T. Kurita, N. Aihara, and S. Kamakura
ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1841 - 1847.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. A.M. Wilde, C. Antzelevitch, M. Borggrefe, J. Brugada, R. Brugada, P. Brugada, D. Corrado, R. N.W. Hauer, R. S. Kass, K. Nademanee, et al.
Proposed Diagnostic Criteria for the Brugada Syndrome: Consensus Report
Circulation, November 5, 2002; 106(19): 2514 - 2519.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A.A.M. Wilde, C. Antzelevitch, M. Borggrefe, J. Brugada, R. Brugada, P. Brugada, D. Corrado, R.N.W. Hauer, R.S. Kass, K. Nademanee, et al.
Proposed Diagnostic Criteria for the Brugada Syndrome
Eur. Heart J., November 1, 2002; 23(21): 1648 - 1654.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R Bezzina and H. L Tan
Pharmacological rescue of mutant ion channels
Cardiovasc Res, August 1, 2002; 55(2): 229 - 232.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Kurita, W. Shimizu, M. Inagaki, K. Suyama, A. Taguchi, K. Satomi, N. Aihara, S. Kamakura, J. Kobayashi, and Y. Kosakai
The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 330 - 334.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. P. P. Smits, L. Eckardt, V. Probst, C. R. Bezzina, J. J. Schott, C. A. Remme, W. Haverkamp, G.u. Breithardt, D. Escande, E. Schulze-Bahr, et al.
Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 350 - 356.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. M. Roden
The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden death
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 357 - 359.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Kanda, W. Shimizu, K. Matsuo, N. Nagaya, A. Taguchi, K. Suyama, T. Kurita, N. Aihara, and S. Kamakura
Electrophysiologic characteristics andimplications of induced ventricular fibrillationin symptomatic patients with brugada syndrome
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1799 - 1805.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. A. Papadatos, P. M. R. Wallerstein, C. E. G. Head, R. Ratcliff, P. A. Brady, K. Benndorf, R. C. Saumarez, A. E. O. Trezise, C. L.-H. Huang, J. I. Vandenberg, et al.
Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a
PNAS, April 18, 2002; (2002) 82121299.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A.A.M. Wilde, C.A. Remme, R. Derksen, E.F.D. Wever, and R.N.W. Hauer
Brugada syndrome
Eur. Heart J., April 2, 2002; 23(8): 675 - 676.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Balser
Inherited sodium channelopathies: models for acquired arrhythmias?
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1175 - H1180.
[Full Text] [PDF]


Home page
CirculationHome page
S. G. Priori, C. Napolitano, M. Gasparini, C. Pappone, P. D. Bella, U. Giordano, R. Bloise, C. Giustetto, R. De Nardis, M. Grillo, et al.
Natural History of Brugada Syndrome: Insights for Risk Stratification and Management
Circulation, March 19, 2002; 105(11): 1342 - 1347.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Shirai, N. Makita, K. Sasaki, H. Yokoi, I. Sakuma, H. Sakurada, J. Akai, A. Kimura, M. Hiraoka, and A. Kitabatake
A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease
Cardiovasc Res, February 1, 2002; 53(2): 348 - 354.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Kyndt, V. Probst, F. Potet, S. Demolombe, J.-C. Chevallier, I. Baro, J.-P. Moisan, P. Boisseau, J.-J. Schott, D. Escande, et al.
Novel SCN5A Mutation Leading Either to Isolated Cardiac Conduction Defect or Brugada Syndrome in a Large French Family
Circulation, December 18, 2001; 104(25): 3081 - 3086.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S H Wong, N T Mulvihill, M Norton, and R. HALL
Assessing the risk of sudden cardiac death
Heart, December 1, 2001; 86(6): 624 - 625.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
B. Martini, S. Cannas, and A. Nava
Brugada by any other name?
Eur. Heart J., October 1, 2001; 22(19): 1835 - 1836.
[PDF]


Home page
CirculationHome page
P. C. Viswanathan, C. R. Bezzina, A. L. George Jr., D. M. Roden, A. A.M. Wilde, and J. R. Balser
Gating-Dependent Mechanisms for Flecainide Action in SCN5A-Linked Arrhythmia Syndromes
Circulation, September 4, 2001; 104(10): 1200 - 1205.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Matsuo, M. Akahoshi, E. Nakashima, A. Suyama, S. Seto, M. Hayano, and K. Yano
The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: A population-based study of four decades
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 765 - 770.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al.
Guidelines on management (diagnosis and treatment) of syncope
Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306.
[Abstract] [PDF]


Home page
HeartHome page
M Furuhashi, K Uno, K Tsuchihashi, D Nagahara, M Hyakukoku, T Ohtomo, S Satoh, T Nishimiya, and K Shimamoto
Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population
Heart, August 1, 2001; 86(2): 161 - 166.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Ikeda, H. Sakurada, K. Sakabe, T. Sakata, M. Takami, N. Tezuka, T. Nakae, M. Noro, Y. Enjoji, T. Tejima, et al.
Assessment of noninvasive markers in identifying patients at risk in the brugada syndrome: insight into risk stratification
J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1628 - 1634.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. M. Roden
Pharmacogenetics and drug-induced arrhythmias
Cardiovasc Res, May 1, 2001; 50(2): 224 - 231.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M Bianco, S Bria, A Gianfelici, N Sanna, V Palmieri, and P Zeppilli
Does early repolarization in the athlete have analogies with the Brugada syndrome?
Eur. Heart J., March 2, 2001; 22(6): 504 - 510.
[Abstract] [PDF]


Home page
Eur Heart JHome page
C Antzelevitch
The Brugada syndrome: diagnostic criteria and cellular mechanisms
Eur. Heart J., March 1, 2001; 22(5): 356 - 363.
[PDF]


Home page
Eur Heart JHome page
C.A Remme, E.F.D Wever, A.A.M Wilde, R Derksen, and R.N.W Hauer
Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation
Eur. Heart J., March 1, 2001; 22(5): 400 - 409.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
D. J. Huelsing, A. E. Pollard, and K. W. Spitzer
Transient outward current modulates discontinuous conduction in rabbit ventricular cell pairs
Cardiovasc Res, March 1, 2001; 49(4): 779 - 789.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R Bezzina, M. B Rook, and A. A.M Wilde
Cardiac sodium channel and inherited arrhythmia syndromes
Cardiovasc Res, February 1, 2001; 49(2): 257 - 271.
[Full Text] [PDF]


Home page
Emerg. Med. J.Home page
J M Butler
Brugada syndrome--the missed epidemic
Emerg. Med. J., November 1, 2000; 17(6): 426 - 428.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. W. Wang, N. Makita, A. Kitabatake, J. R. Balser, and A. L. George Jr
Enhanced Na+ Channel Intermediate Inactivation in Brugada Syndrome
Circ. Res., October 13, 2000; 87 (8): e37 - e43.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S Viskin, R Fish, M Eldar, D Zeltser, M D Lesh, A Glick, and B Belhassen
Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls
Heart, July 1, 2000; 84(1): 31 - 36.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. W. Veldkamp, P. C. Viswanathan, C. Bezzina, A. Baartscheer, A. A. M. Wilde, and J. R. Balser
Two Distinct Congenital Arrhythmias Evoked by a Multidysfunctional Na+ Channel
Circ. Res., May 12, 2000; 86 (9): e91 - e97.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Martini, A. Nava, D. Corrado, G. Thiene, A. Wilde, and M. Alings
Right Bundle-Branch Block, ST-Segment Elevation, and Sudden Death Response
Circulation, April 25, 2000; 101 (16): e176 - e176.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. A.M. Wilde and M. W. Veldkamp
What we can learn from individual resuscitated patients
Cardiovasc Res, April 1, 2000; 46(1): 14 - 16.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. Deschenes, G. Baroudi, M. Berthet, I. Barde, T. Chalvidan, I. Denjoy, P. Guicheney, and M. Chahine
Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes
Cardiovasc Res, April 1, 2000; 46(1): 55 - 65.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P Brugada, R Brugada, and J Brugada
Sudden death in patients and relatives with the syndrome of right bundle branch block, ST segment elevation in the precordial leads V1to V3and sudden death
Eur. Heart J., February 2, 2000; 21(4): 321 - 326.
[Abstract] [PDF]


Home page
CirculationHome page
N. Makita, N. Shirai, D. W. Wang, K. Sasaki, A. L. George Jr, M. Kanno, and A. Kitabatake
Cardiac Na+ Channel Dysfunction in Brugada Syndrome Is Aggravated by {beta}1-Subunit
Circulation, January 4, 2000; 101(1): 54 - 60.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Bezzina, M. W. Veldkamp, M. P. van den Berg, A. V. Postma, M. B. Rook, J.-W. Viersma, I. M. van Langen, G. Tan-Sindhunata, M. Th. E. Bink-Boelkens, A. H. van der Hout, et al.
A Single Na+ Channel Mutation Causing Both Long-QT and Brugada Syndromes
Circ. Res., December 3, 1999; 85(12): 1206 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. B. Rook, C. Bezzina Alshinawi, W.A. Groenewegen, I. C. van Gelder, A. C.G. van Ginneken, H. J. Jongsma, M. M.A.M. Mannens, and A. A.M. Wilde
Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome
Cardiovasc Res, December 1, 1999; 44(3): 507 - 517.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Dumaine, J. A. Towbin, P. Brugada, M. Vatta, D. V. Nesterenko, V. V. Nesterenko, J. Brugada, R. Brugada, and C. Antzelevitch
Ionic Mechanisms Responsible for the Electrocardiographic Phenotype of the Brugada Syndrome Are Temperature Dependent
Circ. Res., October 29, 1999; 85(9): 803 - 809.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. R. Balser
Sodium "Channelopathies" and Sudden Death : Must You Be So Sensitive?
Circ. Res., October 29, 1999; 85(9): 872 - 874.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. A. Papadatos, P. M. R. Wallerstein, C. E. G. Head, R. Ratcliff, P. A. Brady, K. Benndorf, R. C. Saumarez, A. E. O. Trezise, C. L.-H. Huang, J. I. Vandenberg, et al.
From the Cover: Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a
PNAS, April 30, 2002; 99(9): 6210 - 6215.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Wichter, P. Matheja, L. Eckardt, P. Kies, K. Schafers, E. Schulze-Bahr, W. Haverkamp, M. Borggrefe, O. Schober, G. Breithardt, et al.
Cardiac Autonomic Dysfunction in Brugada Syndrome
Circulation, February 12, 2002; 105(6): 702 - 706.
[Abstract] [Full Text] [PDF]